The HeartFelt program provides medication replacement of Menopur (menotropins for injection) and generic Ganirelix Acetate Injection for eligible cash-paying patients, or up to $250 in assistance towards co-pay costs for eligible commercially insured patients whose controlled ovarian stimulation (COS) cycles were canceled as a result of the COVID-19 pandemic or a natural disaster resulting in a federal or state of emergency. Terms and conditions apply.